Related Experiment Video
Updated: May 22, 2026
19:57
An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
Pharmacovigilance and global HIV/AIDS
Veronica Miller1, Jude Nwokike, Andy Stergachis
1Forum for Collaborative HIV Research, School of Public Health, University of California Berkeley, USA. veronicam@berkeley.edu
Current Opinion in HIV and AIDS
|May 26, 2012
Summary
Global pharmacovigilance for HIV/AIDS treatment faces challenges despite millions on antiretroviral drugs. Strengthening safety monitoring and fostering industry collaboration are crucial for long-term program success and patient health.
Area of Science:
- Pharmacovigilance
- Global Health
- HIV/AIDS Treatment
Background:
- Over 6 million people globally receive HIV/AIDS treatment with numerous antiretroviral drugs.
- Program sponsorship (Global Fund, PEPFAR) and generic drug availability have driven treatment access.
- Regulatory bodies like WHO and US FDA facilitate generic drug approval for these programs.
Purpose of the Study:
- To review the current status, progress, challenges, and opportunities in global pharmacovigilance for HIV/AIDS treatment.
- To highlight the need for enhanced drug safety monitoring systems.
- To explore innovative approaches for improving pharmacovigilance in resource-limited settings.
Main Methods:
- Review of existing literature and program data on HIV/AIDS pharmacovigilance.
- Analysis of regulatory processes for antiretroviral drugs.
- Identification of potential data sources for safety monitoring, including cohort studies and electronic records.
Main Results:
- Despite widespread treatment, adequate post-distribution drug safety monitoring systems are often lacking.
- The pharmaceutical industry's role in pharmacovigilance for HIV/AIDS treatment remains underdeveloped.
- Collaboration between industry, clinical programs, and health authorities is identified as essential.
Conclusions:
- Ensuring drug quality and safety is vital for the sustainability of HIV/AIDS treatment programs.
- Systematic, collaborative pharmacovigilance approaches utilizing diverse data sources are necessary.
- Strengthening pharmacovigilance contributes to overall health system improvement.
Related Concept Videos
01:19Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
01:03Drug Control Governance: Regulatory Bodies and Their Impact
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with a...
01:28International Nursing Organizations II
The World Health Organization (WHO) is a specialized agency of the United Nations based in Geneva. The WHO has many initiatives that center around health. Primarily, they lead global efforts to expand universal health coverage using science-based policies and programs. They are also responsible for shaping health research agendas and developing norms and standards.
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...